These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury. Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226 [TBL] [Abstract][Full Text] [Related]
5. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10. Nold M; Goede A; Eberhardt W; Pfeilschifter J; Mühl H Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):68-75. PubMed ID: 12616343 [TBL] [Abstract][Full Text] [Related]
6. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211 [TBL] [Abstract][Full Text] [Related]
7. Regulatory role of 1, 25-dihydroxyvitamin D3 and vitamin D receptor gene variants on intracellular granzyme A expression in pulmonary tuberculosis. Vidyarani M; Selvaraj P; Raghavan S; Narayanan PR Exp Mol Pathol; 2009 Feb; 86(1):69-73. PubMed ID: 19014932 [TBL] [Abstract][Full Text] [Related]
8. Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro. Asano K; Kanai KI; Suzaki H Clin Exp Allergy; 2004 Dec; 34(12):1890-8. PubMed ID: 15663564 [TBL] [Abstract][Full Text] [Related]
9. Interferon gamma gene +874A/T polymorphism and intracellular interferon gamma expression in pulmonary tuberculosis. Prabhu Anand S; Harishankar M; Selvaraj P Cytokine; 2010 Feb; 49(2):130-3. PubMed ID: 20004112 [TBL] [Abstract][Full Text] [Related]
10. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes]. Florys B; Głowińska B; Urban M; Peczyńska J Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):184-9. PubMed ID: 17020653 [TBL] [Abstract][Full Text] [Related]
11. Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro. Shimizu T; Kanai K; Kyo Y; Asano K; Hisamitsu T; Suzaki H J Pharm Pharmacol; 2006 Jan; 58(1):91-9. PubMed ID: 16393468 [TBL] [Abstract][Full Text] [Related]
12. Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs. Gilli F; Bertolotto A; Sala A; Hoffmann F; Capobianco M; Malucchi S; Glass T; Kappos L; Lindberg RL; Leppert D Brain; 2004 Feb; 127(Pt 2):259-68. PubMed ID: 14607790 [TBL] [Abstract][Full Text] [Related]
13. Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Mautino G; Henriquet C; Gougat C; Le Cam A; Dayer JM; Bousquet J; Capony F Lab Invest; 1999 Jan; 79(1):39-47. PubMed ID: 9952109 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta. Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833 [TBL] [Abstract][Full Text] [Related]
15. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease]. Xu XM; Sun TY; Lin JB; Zhang HS Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631 [TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis. Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092 [TBL] [Abstract][Full Text] [Related]
17. Metalloproteinases and their tissue inhibitors in multiple sclerosis. Ozenci V; Rinaldi L; Teleshova N; Matusevicius D; Kivisäkk P; Kouwenhoven M; Link H J Autoimmun; 1999 Jun; 12(4):297-303. PubMed ID: 10330301 [TBL] [Abstract][Full Text] [Related]
18. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension. Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028 [TBL] [Abstract][Full Text] [Related]
19. Production of matrix metalloproteinases and their inhibitors in osteoarthritic patients undergoing mud bath therapy. Bellometti S; Richelmi P; Tassoni T; Bertè F Int J Clin Pharmacol Res; 2005; 25(2):77-94. PubMed ID: 16060398 [TBL] [Abstract][Full Text] [Related]
20. [Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis]. Klimiuk PA; Sierakowski S; Chwiećko J Pol Merkur Lekarski; 2003 May; 14(83):410-2. PubMed ID: 12939814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]